Both TRPM4 and KCTD5 mRNA expression was shown to be increased in triple negative samples, a more aggressive subtype of breast cancer that lacks specialized treatment [111,112], as well as in ER+/PR+ samples. The gene discussed is TRPM4; the disease is breast cancer.